Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Tomoko Hamaya"'
Autor:
Tomoko Hamaya, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Hirotake Kodama, Takeshi Fujita, Reiichi Murakami, Kazuyuki Mori, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Hisao Saitoh, Shunji Narumi, Hirofumi Tomita, Chikara Ohyama
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract We aimed to evaluate the humoral response after the second and third doses of SARS-CoV-2 mRNA vaccine in ABO blood type incompatible kidney transplant (KT) recipients treated with rituximab. This retrospective study conducted between June 20
Externí odkaz:
https://doaj.org/article/3f7ccf5e416d46c6a7cff32e5a334931
Autor:
Tomoko Hamaya, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Hirotake Kodama, Takeshi Fujita, Reiichi Murakami, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Hisao Saitoh, Shunji Narumi, Hirofumi Tomita, Chikara Ohyama
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-7 (2022)
Abstract We aimed to evaluate the seroprevalence and investigated factors associated with seropositivity after the second SARS-CoV-2 mRNA vaccination in kidney transplant (KT) recipients. This retrospective study conducted between June and November 2
Externí odkaz:
https://doaj.org/article/2eff230bfea644a8b44b8c662ee172c2
Autor:
Itsuto Hamano, Shingo Hatakeyama, Tomoko Hamaya, Kyo Togashi, Teppei Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Publikováno v:
IJU Case Reports, Vol 3, Iss 4, Pp 141-144 (2020)
Introduction Cell‐free DNA is suggested as a prognostic biomarker in metastatic castration‐resistant prostate cancer. However, it remains unknown which parameter of cell‐free DNA is correlated with the progression and prognosis of metastatic ca
Externí odkaz:
https://doaj.org/article/2246fa5a797547139ea50004ce11ae88
Autor:
Yusuke Ozaki, Takuma Narita, Shingo Hatakeyama, Toshikazu Tanaka, Kyo Togashi, Tomoko Hamaya, Kai Ozaki, Noritaka Ishi, Takuya Oishi, Noriko Tokui, Jotaro Mikami, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Publikováno v:
Translational Andrology and Urology. 12:161-167
Autor:
Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Tomoko Hamaya, Yuki Tobisawa, Tohru Yoneyama, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama
Publikováno v:
Andrology. 10:1548-1555
Low-grade systemic inflammation and malnutrition are frequently observed in patients on dialysis and contribute to the development of endothelial dysfunction; however, the role of these conditions in erectile dysfunction (ED) severity remains to be e
Autor:
Kyo Togashi, Shingo Hatakeyama, Tohru Yoneyama, Tomoko Hamaya, Takuma Narita, Naoki Fujita, Hiromichi Iwamura, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Publikováno v:
International Journal of Urology. 29:733-739
To evaluate the serologic response to the BNT162b2 messenger ribonucleic acid vaccine in patients with urothelial carcinoma and renal cell carcinoma.Between June 2021 and November 2021, we retrospectively evaluated blood samples from 60 healthy contr
Autor:
Hirotake Kodama, Shingo Hatakeyama, Tomoko Hamaya, Reiichi Murakami, Hiromi Murasawa, Hayato Yamamoto, Takahiro Yoneyama, Chikara Ohyama
Publikováno v:
Transplantation Proceedings. 54:1601-1603
Noonan syndrome (NS) is a congenital genetic abnormality characterized by short stature, delayed onset of puberty, cardiac malformations, and characteristic external malformations. Congenital chromosomal or genetic abnormalities are sometimes associa
Autor:
Kai Ozaki, Shingo Hatakeyama, Shintaro Narita, Kenichi Hata, Takafumi Yanagisawa, Toshikazu Tanaka, Kyo Togashi, Tomoko Hamaya, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Takahiro Kimura, Tomonori Habuchi, Chikara Ohyama
Publikováno v:
World journal of urology.
We compared the real-world efficacy and medical costs for treatment with upfront docetaxel (DOC) and abiraterone acetate (ABI) up to progression-free survival 2 (PFS2) in patients with metastatic hormone-sensitive prostate cancer (mHSPC).This multice
Autor:
Ryuma Tanaka, Shingo Hatakeyama, Hikari Miura, Tomoko Hamaya, Takahiro Yoneyama, Chikara Ohyama
Publikováno v:
International journal of urology : official journal of the Japanese Urological AssociationREFERENCES. 29(10)
Autor:
Shingo Hatakeyama, Tohru Yoneyama, Tomoko Hamaya, Kyo Togashi, Takuma Narita, Naoki Fujita, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Publikováno v:
Journal of Urology. 207